Find Grants for Higher Education
Find out if you qualify for verified grants for Higher Education. Discover your eligibility and key funding details for Higher Education from major foundations and government agencies.
Supporting Talented Early Career Researchers in Genomics (R01 Clinical Trial Optional)
Deadline: February 26, 2027
Opportunity Number: RFA-HG-25-009
Agency: National Institutes of Health
Open Date: December 16, 2024
Close Date: February 26, 2027
Status: Posted
CFDA Numbers: 93.172
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
Deadline: November 15, 2027
Opportunity Number: PAR-25-336
Agency: National Institutes of Health
Open Date: December 16, 2024
Close Date: November 15, 2027
Status: Posted
CFDA Numbers: 93.395
Institutional Training Programs to Advance Translational Research on Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (T32 Clinical Trial Not Allowed)
Deadline: September 25, 2026
Opportunity Number: PAR-25-247
Agency: National Institutes of Health
Open Date: December 13, 2024
Close Date: September 25, 2026
Status: Posted
CFDA Numbers: 93.866
Integrating Biospecimen Science Approaches into Clinical Assay Development (U01 Clinical Trial Not Allowed)
Deadline: September 10, 2027
Opportunity Number: PAR-25-325
Agency: National Institutes of Health
Open Date: December 13, 2024
Close Date: September 10, 2027
Status: Posted
CFDA Numbers: 93.393
Risk and Protective Factors of Family Health and Family Level Interventions (R01 Clinical Trial Optional)
Deadline: May 8, 2027
Opportunity Number: PAR-25-317
Agency: National Institutes of Health
Open Date: December 13, 2024
Close Date: May 8, 2027
Status: Posted
CFDA Numbers: 93.313, 93.307, 93.399, 93.273, 93.310, 93.361
Clinical Coordinating Center for Multi-Site Investigator-Initiated Clinical Trials (Collaborative UG3/UH3 Clinical Trial Required)
Deadline: January 11, 2026
Opportunity Number: PAR-25-029
Agency: National Institutes of Health
Open Date: December 11, 2024
Close Date: January 11, 2026
Status: Posted
CFDA Numbers: 93.840, 93.838, 93.233, 93.837, 93.839
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-346
Agency: National Institutes of Health
Open Date: December 11, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.394, 93.393, 93.121, 93.396, 93.395, 93.399
HEAL Initiative-Early-Stage Discovery of New Pain Targets Within the Understudied Druggable Proteome (R03 Clinical Trial Not Allowed)
Deadline: July 16, 2026
Opportunity Number: PAR-25-154
Agency: National Institutes of Health
Open Date: December 11, 2024
Close Date: July 16, 2026
Status: Posted
CFDA Numbers: 93.853, 93.846, 93.273, 93.865, 93.866, 93.121, 93.213, 93.279, 93.350
High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
Deadline: October 15, 2027
Opportunity Number: PAR-25-277
Agency: National Institutes of Health
Open Date: December 11, 2024
Close Date: October 15, 2027
Status: Posted
CFDA Numbers: 93.847
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
Deadline: October 19, 2027
Opportunity Number: PAR-25-296
Agency: National Institutes of Health
Open Date: December 11, 2024
Close Date: October 19, 2027
Status: Posted
CFDA Numbers: 93.846, 93.855, 93.307, 93.350, 93.172, 93.859, 93.865, 93.121, 93.313
Limited Competition: Small Grant Program for the NCATS Clinical and Translational Science Award (CTSA) Program (R03 Clinical Trial Optional)
Deadline: October 19, 2026
Opportunity Number: PAR-25-155
Agency: National Institutes of Health
Open Date: December 11, 2024
Close Date: October 19, 2026
Status: Posted
CFDA Numbers: 93.350
Single-Site Investigator-Initiated Clinical Trials (R61/R33 Clinical Trial Required)
Deadline: January 11, 2026
Opportunity Number: PAR-25-028
Agency: National Institutes of Health
Open Date: December 11, 2024
Close Date: January 11, 2026
Status: Posted
CFDA Numbers: 93.838, 93.233, 93.839, 93.840, 93.837
Awards Supporting Cutting-Edge Technologies for Translational Science (ASCETTS) (R21 Clinical Trials Not Allowed)
Deadline: June 18, 2026
Opportunity Number: PAR-25-157
Agency: National Institutes of Health
Open Date: December 10, 2024
Close Date: June 18, 2026
Status: Posted
CFDA Numbers: 93.350
Exploratory/Developmental Bioengineering Research Grants (EBRG) (R21 Clinical Trial Optional)
Deadline: January 7, 2028
Opportunity Number: PAR-25-321
Agency: National Institutes of Health
Open Date: December 10, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.394, 93.395, 93.393, 93.399, 93.396
Limited Competition: High Impact Specialized Innovation Programs in Clinical and Translational Science (RC2 Clinical Trials Optional)
Deadline: September 28, 2026
Opportunity Number: PAR-25-156
Agency: National Institutes of Health
Open Date: December 10, 2024
Close Date: September 28, 2026
Status: Posted
CFDA Numbers: 93.350
Limited Competition: Mentored Research Career Development Program Award in Clinical and Translational Science Awards (CTSA) Program (K12 Clinical Trial Optional)
Deadline: September 28, 2027
Opportunity Number: PAR-25-196
Agency: National Institutes of Health
Open Date: December 10, 2024
Close Date: September 28, 2027
Status: Posted
CFDA Numbers: 93.350
BRAIN Initiative: New Concepts and Early-Stage Research for Recording and Modulation in the Nervous System (R21) (Clinical Trial Not Allowed)
Deadline: June 15, 2026
Opportunity Number: RFA-EY-25-001
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: June 15, 2026
Status: Posted
CFDA Numbers: 93.173, 93.286, 93.213, 93.865, 93.866, 93.853, 93.867, 93.273, 93.242, 93.279
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
Deadline: November 2, 2026
Opportunity Number: PAR-24-280
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: November 2, 2026
Status: Posted
CFDA Numbers: 93.846
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
Deadline: November 2, 2026
Opportunity Number: PAR-24-279
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: November 2, 2026
Status: Posted
CFDA Numbers: 93.846
Limited Competition: NCATS Clinical and Translational Science Award (CTSA) Program Research Education Grants Programs (R25 - Clinical Trial Not Allowed)
Deadline: May 28, 2027
Opportunity Number: PAR-25-197
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: May 28, 2027
Status: Posted
CFDA Numbers: 93.350
NIAMS Clinical Trial Implementation Cooperative Agreement (UG3/UH3 Clinical Trial Required)
Deadline: March 4, 2027
Opportunity Number: PAR-25-141
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: March 4, 2027
Status: Posted
CFDA Numbers: 93.846
Role of Defective Proviruses in HIV Persistence (R01 Clinical Trial Not Allowed)
Deadline: January 7, 2028
Opportunity Number: PAR-25-330
Agency: National Institutes of Health
Open Date: December 9, 2024
Close Date: January 7, 2028
Status: Posted
CFDA Numbers: 93.847, 93.242, 93.855, 93.865
Interventions to Reduce Sleep Health Disparities (R01 - Clinical Trials Optional)
Deadline: September 7, 2027
Opportunity Number: PAR-24-330
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: September 7, 2027
Status: Posted
CFDA Numbers: 93.838, 93.839, 93.273, 93.866, 93.853, 93.361, 93.399, 93.837, 93.840, 93.233, 93.307
Pilot Health Services and Economic Research on the Treatment of Drug, Alcohol, and Tobacco Use Disorders (R34 Clinical Trial Optional)
Deadline: May 7, 2027
Opportunity Number: PAR-25-100
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: May 7, 2027
Status: Posted
CFDA Numbers: 93.279
Preclinical Proof of Concept Studies for Rare Diseases (R21 Clinical Trial Not Allowed)
Deadline: June 2, 2026
Opportunity Number: RFA-TR-25-002
Agency: National Institutes of Health
Open Date: December 6, 2024
Close Date: June 2, 2026
Status: Posted
CFDA Numbers: 93.350
